GLP-1 RAs may reduce opioid overdose risk by 40%People with opioid or alcohol use disorder (OUD, AUD) who take glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to treat...
LRYFJ for the treatment of chronic gastric leaks after LSGLaparoscopic Roux-en-Y fistulojejunostomy (LRYFJ) is an appropriate surgical option for the treatment of chronic gastric leaks after...
Expanding access to weight-loss drugs could save thousands of lives a yearExpanding access to the new generation of weight-loss medications could prevent more than 40,000 deaths a year in the US, according to a...
Bariatric surgery found to be more cost effective than GLP-1 RAs aloneGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are cost effective in the long term only when combined with bariatric surgery,...
Phenomix Sciences and InformedDNA enter partnership to advance genetics-driven obesity carePhenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...
Banded-RYGB associated with statistically significant increases in percentage excess weight loss at five yearsBanded- Roux-en-Y gastric bypass (RYGB) is associated with statistically significant increases in percentage excess weight loss (% EWL)...